Not “game-changing” but another positive step forward for evidenced-based treatment to help people with #Overweight or #Obesity.

Sunday House Call, #777, February 14, 2021

This week the NEJM published a study concluding “In participants with overweight or obesity, 2.4 mg of semaglutide once weekly plus lifestyle intervention was associated with sustained, clinically relevant reduction in body weight.”

A follow up editorial provides some perspective.

Your calls about:

  • Can mouthwash and nasal rinses prevent Covid-19 infections?
  • What are the clinical indications for intubation?
  • The appearance of variants in Canada and around the world. Do they share similar mutations?
  • Blood pressure checks.

References:
A discussion with the co-author of Canada’s weight management guidelines Dr. Sean Wharton

Dr. David Macklin discusses what we know about the influences on our appetite and weight.

Bitnami